The Silent Epidemic: How Systemic Failures Fuel Pakistan’s Hepatitis Crisis

April 23, 2026

TAUNSA, PAKISTAN — A devastating pediatric HIV outbreak in Punjab province has pulled back the curtain on a much broader, deadlier public health crisis: a “silent” hepatitis epidemic driven by the very institutions meant to provide healing. Following a year-long investigation into the Tehsil Headquarters (THQ) Hospital in Taunsa, where 331 children tested positive for HIV between late 2024 and October 2025, health authorities and international observers are warning that the same systemic failures—reused syringes and poor sterilization—are fueling one of the world’s highest rates of hepatitis B and C.

A Systemic Breakdown in Care

The crisis reached a tipping point this week following undercover footage released by BBC Eye. The report documented hospital staff at the Taunsa facility reusing syringes and handling patients without basic infection control protocols—months after provincial officials had publicly pledged a crackdown on unsafe practices.

Perhaps most telling was the epidemiological data: fewer than 5% of the parents of the HIV-positive children tested positive themselves. This suggests that the primary driver of the outbreak was not mother-to-child transmission, but iatrogenic—infections caused by medical treatment itself.

“This is a wake-up call that extends far beyond one hospital or one virus,” says Dr. Arshad Khan, a public health consultant not involved in the original report. “The same needle that transmits HIV transmits Hepatitis C (HCV) with even greater efficiency. In many ways, the HIV numbers are just the tip of the iceberg.”

The Scale of a Staggering Burden

Pakistan currently grapples with a hepatitis burden that ranks among the heaviest globally. According to 2025 data from the World Health Organization (WHO), approximately 13.8 million Pakistanis are living with chronic hepatitis:

• Hepatitis C (HCV): ~10 million people

• Hepatitis B (HBV): ~3.8 million people

The most alarming statistic involves the mode of transmission. In Pakistan, the WHO estimates that 62% of new HCV infections are linked to unsafe medical injections and contaminated blood products. Unlike many Western nations where transmission is often linked to injection drug use, Pakistan’s epidemic is largely “provider-driven.”

“We are seeing a cycle where patients seek low-cost care for minor ailments and leave with a life-long, life-threatening infection,” notes a recent editorial in The Express Tribune. Currently, only 25% to 30% of those infected in Pakistan are aware of their status, leading to a “silent” spread that often remains undetected until it progresses to cirrhosis or liver cancer.

Why the Epidemic Remains “Silent”

Hepatitis C is frequently asymptomatic for decades. A patient may feel perfectly healthy while the virus slowly causes liver scarring. By the time symptoms like jaundice (yellowing of the skin), chronic fatigue, or abdominal swelling appear, the damage is often irreversible.

The Government’s Ambitious Counter-Offensive

In response to the mounting pressure, the Pakistani government, in collaboration with the WHO, has intensified the Prime Minister’s National Programme for the Elimination of Hepatitis C. The goals are historic in scale:

1. Mass Screening: Aiming to test 82.5 million people (50% of the eligible population) by 2027.

2. Expanded Treatment: Target of treating 5 million people with highly effective direct-acting antivirals (DAAs) within the next year.

3. Long-term Impact: Projections suggest these efforts could avert 850,000 deaths and 1.1 million new infections by 2050.

However, experts argue that screening is only half the battle. “You cannot mop up the floor while the tap is still running,” says Dr. Khan. “Until there is a cultural shift in infection control and strict regulation of the ‘informal’ medical sector, new infections will continue to replace those we cure.”

Limitations and Practical Challenges

While the evidence of unsafe care is compelling, researchers note certain limitations. Much of the recent data comes from investigative journalism and provincial screening records rather than peer-reviewed epidemiological studies. While the trend is clear, the exact percentage of infections stemming from specific hospitals versus community settings can be difficult to pin down.

Furthermore, Pakistan’s decentralized healthcare system makes the enforcement of “Single-Use Needle” policies challenging in rural outposts where resources are scarce and oversight is minimal.

What This Means for the Public

For the average citizen, the crisis highlights the necessity of “active patienthood.” Health literacy is the first line of defense. Public health officials recommend the following:

• Demand Transparency: Always ensure a syringe is taken from a fresh, sealed packet in your presence.

• Screening: If you have received a medical procedure, dental work, or a transfusion in an unregulated facility, seek a hepatitis screening.

• Vaccination: Ensure family members are vaccinated against Hepatitis B (there is currently no vaccine for Hepatitis C).

• Professional Care: Avoid “street doctors” or unlicensed practitioners who may reuse equipment to save costs.

The tragedy in Taunsa serves as a somber reminder: in the pursuit of health, the system must first do no harm.

Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.

References

• https://tennews.in/pakistan-faces-hepatitis-surge-due-to-negligence-and-unchecked-medical-culture/